连续血糖监测系统对 2 型糖尿病患者血糖控制效果的证据总结
摘要
测仪对 2 型糖尿病患者血糖管理的相关文献，根据相关文献评价标准进行评价并提取证据。结果 共纳入 17 篇文献，包括
指南 3 篇，系统评价 12 篇，专家共识 2 篇，从血糖指标、血糖波动、使用连续血糖监测仪不良事件、血糖管理依从性 4 个
方面共提取出 12 条最佳证据。结论 持续血糖监测有利于 2 型糖尿病患者血糖指标的改善，将证据转化为 2 型糖尿病患者
自我管理方案，把持续血糖监测应用在 2 型糖尿病患者中，以期提高血糖管理的依从性，帮助患者控制血糖，最终改善其
临床症状与预后、提高生活质量。
关键词
全文:
PDF参考
[1] International Diabetes Federation. IDF Diabetes Atlas,
10th edn. Brussels, Belgium: 2021. Available at: https://www.
diabetesatlas.org
[2] 中华医学会糖尿病学分会 . 中国 2 型糖尿病防治指
南 (2020 年版 )[J]. 国际内分泌代谢杂志 , 2021, 41(05):482-
548.
[3] Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases
developed in collaboration with the EASD [J]. Eur Heart J, 2020,
41(2):255-323.
[4] 中华医学会糖尿病学分会 . 中国血糖监测临床应用
指 南（2021 年 版）. 中 华 糖 尿 病 杂 志，2021，13(10):936-
948.
[5] Teo, E., Hassan, N., Tam, W., & Koh, S. (2022).
Effectiveness of continuous glucose monitoring in maintaining
glycaemic control among people with type 1 diabetes mellitus:
a systematic review of randomised controlled trials and meta-
analysis. Diabetologia, 65(4), 604-619.
[6] 李佳旻 . 2 型糖尿病患者自我血糖监测的现况、影响
因素及其与血糖控制的关系 [D]. 上海 : 复旦大学 ,2007.
[7] 陈 俊 键 , 范 冠 华 . 社 区 血 糖 管 理 人 群 血 糖 自
我 监 测 达 标 情 况 及 其 影 响 因 素 研 究 [J]. 中 国 全 科 医
学 ,2022,25(34):4298-4303.
[8] 熊怡 , 吴冬梅 , 毛国菊 , 等 . 中国 2 型糖尿病自我血
糖监测频率达标率及其影响因素的 Meta 分析 [J]. 现代预防
医学 ,2024,51(03):507-513.
[9] Brouwers MC, Kho ME, Browman GP, et al. AGREE II:
advancing guideline development, reporting, and evaluation in
health care. Prev Med. 2010;51(5):421-424.
[10] 顾莺 , 张慧文 , 周英凤 , 等 .JBI 循证卫生保健中心
关于不同类型研究的质量评价工具——系统评价的方法学
质量评价 [J]. 护士进修杂志 ,2018,33(08):701-703.
[11] 王春青 , 胡雁 . JBI 证据预分级及证据推荐级别系统
（2014 版）[J]. 护士进修杂志 ,2015(11):964-967.
[12] 邢唯杰 , 胡雁 , 周英凤 , 等 . 推动证据向临床转化 ( 六 )
证据总结的制作与撰写 [J]. 护士进修杂志 ,2020,35(12):1129-
1132.
[13] Park, C., & Le, Q. A. (2018). The Effectiveness of
Continuous Glucose Monitoring in Patients with Type 2 Diabetes:
A Systematic Review of Literature and Meta-analysis. Diabetes
technology & therapeutics, 20(9), 613–621.
[14] Ida, S., Kaneko, R., & Murata, K. (2019). Utility of
Real-Time and Retrospective Continuous Glucose Monitoring
in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of
Randomized Controlled Trials. Journal of diabetes research, 2019,
4684815.
[15] Gandhi, G. Y., Kovalaske, M., Kudva, Y., Walsh, K.,
Elamin, M. B., Beers, M., Coyle, C., Goalen, M., Murad, M. S.,
Erwin, P. J., Corpus, J., Montori, V. M., & Murad, M. H. (2011).
Efficacy of continuous glucose monitoring in improving glycemic
control and reducing hypoglycemia: a systematic review and metaanalysis of randomized trials. Journal of diabetes science and
technology, 5(4), 952–965.
[16] Poolsup N, Suksomboon N, Kyaw AM. Systematic review
and meta-analysis of the effectiveness of continuous glucose
monitoring (CGM) on glucose control in diabetes. Diabetol Metab
Syndr. 2013;5:39.
[17] Di Molfetta, S., Caruso, I., Cignarelli, A., Natalicchio,
A., Perrini, S., Laviola, L., & Giorgino, F. (2023). Professional
continuous glucose monitoring in patients with diabetes mellitus:
A systematic review and meta-analysis. Diabetes, obesity &
metabolism, 25(5), 1301–1310.
[18] Seidu S, Setor K. Kunutsor, Ramzi A. Ajjan, Pratik
Choudhary; Efficacy and Safety of Continuous Glucose Monitoring
and Intermittently Scanned Continuous Glucose Monitoring in
Patients With Type 2 Diabetes: A Systematic Review and Metaanalysis of Interventional Evidence. Diabetes Care 2 January
2024; 47 (1): 169–179.
[19] Jancev M, Vissers TACM, Visseren FLJ, et al.
Continuous glucose monitoring in adults with type 2 diabetes:
a systematic review and meta-analysis. Diabetologia.
2024;67(5):798-810.
[20] Ferreira ROM, Trevisan T, Pasqualotto E, et al.
Continuous Glucose Monitoring Systems in Noninsulin-Treated
People with Type 2 Diabetes: A Systematic Review and MetaAnalysis of Randomized Controlled Trials. Diabetes Technol Ther.
2024;26(4):252-262.
[21] Uhl S, Choure A, Rouse B, Loblack A, Reaven P.
Effectiveness of Continuous Glucose Monitoring on Metrics of
Glycemic Control in Type 2 Diabetes Mellitus: A Systematic
Review and Meta-analysis of Randomized Controlled Trials. J
Clin Endocrinol Metab. 2024;109(4):1119-1131.
[22] Dicembrini I, Mannucci E, Monami M, Pala L. Impact
of technology on glycaemic control in type 2 diabetes: A metaanalysis of randomized trials on continuous glucose monitoring and
continuous subcutaneous insulin infusion. Diabetes Obes Metab.
2019;21(12):2619-2625.
[23] Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda,
Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer,
Billy S. Collins, Marisa E. Hilliard, Diana Isaacs, Eric L. Johnson,
Scott Kahan, Kamlesh Khunti, Jose Leon, Sarah K. Lyons, Mary
Lou Perry, Priya Prahalad, Richard E. Pratley, Jane Jeffrie Seley,
Robert C. Stanton, Robert A. Gabbay; on behalf of the American
Diabetes Association, 7. Diabetes Technology: Standards of
Care in Diabetes—2023. Diabetes Care 1 January 2023; 46
(Supplement_1): S111–S127.
[24] Janapala, R. N., Jayaraj, J. S., Fathima, N., Kashif,
T., Usman, N., Dasari, A., Jahan, N., & Sachmechi, I. (2019).
Continuous Glucose Monitoring Versus Self-monitoring of Blood
Glucose in Type 2 Diabetes Mellitus: A Systematic Review with
Meta-analysis. Cureus, 11(9), e5634.
[25]Lu J, Ying Z, Wang P, Fu M, Han C, Zhang M.
Effects of continuous glucose monitoring on glycaemic control
in type 2 diabetes: A systematic review and network metaanalysis of randomized controlled trials. Diabetes Obes Metab.
2024;26(1):362-372.
[26]Krakauer M, Gómez AM, Almeda-Valdes P, et al.
Type 2 diabetes in latin America: recommendations on the flash
glucose monitoring system. Diabetol Metab Syndr. 2024;16(1):106.
Published 2024 May 20.
[27]Kong APS, Lim S, Yoo SH, et al. Asia-Pacific
consensus recommendations for application of continuous glucose
monitoring in diabetes management. Diabetes Res Clin Pract.
2023;201:110718.
[28] 中华医学会糖尿病学分会 . 中国持续葡萄糖监测
临 床 应 用 指 南（2017 年 版）. 中 华 糖 尿 病 杂 志，2017，
09(11):667-675.
(3 摘要 Views, 5 PDF Downloads)
Refbacks
- 当前没有refback。